Evidence map›Paper›PMID 38839547›Full record

ArticleHematology, transfusion and cell therapy2024

Pregnant women's knowledge and clinical management of hemolytic disease of the fetus and newborn in Pará, Brazil.

Jhemily de Nazaré Gonçalves E Silva, Andrya Maia de Souza, Fabiane Monteiro do Rosario, Laine Celestino Pinto

Abstract read
In one paragraph

Article in Hematology, transfusion and cell therapy, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Jhemily de Nazaré Gonçalves E SilvaImumunogenetics Laboratory, Federal University of Pará, Biological Science Institute, Belém, Pará, Brazil.
Andrya Maia de SouzaDepartment of Biomedicine, Centro Universitário Metropolitano da Amazônia, Belém, Pará, Brazil.
Fabiane Monteiro do RosarioDepartment of Biomedicine, Centro Universitário Metropolitano da Amazônia, Belém, Pará, Brazil.
Laine Celestino PintoDepartment of Biomedicine, Centro Universitário Metropolitano da Amazônia, Belém, Pará, Brazil; Laboratory of Experimental Neuropathology, Federal University of Pará, Biological Science Institute, Belém, Pará, Brazil. Electronic address: laine@famaz.edu.br.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo evaluate the knowledge of pregnant women and the clinical management of hemolytic disease of the fetus and newborn, as well as to describe the gestational profile, risk factors and socio-epidemiological profile of pregnant women treated at two municipal health units in Belém (Pará, Brazil).

methodsThis was a cross-sectional analytical study, which consisted in the application of questionnaires to pregnant women who underwent prenatal care at the municipal health units.

resultsA total of 104 pregnant women were evaluated; most were aged between 24 and 29 years old, had high school degrees (38 %), family incomes between 1 and 2 minimum wages (45 %) and blood type O+ (43 %). Regarding the gestational profile, the participants were predominantly in the third trimester of pregnancy (49 %), started prenatal care in the first gestational trimester (81 %) and were primiparous (61 %). Failures in the management of prenatal care were observed, especially with regard to access to information about the disease, since most pregnant women did not receive information about blood incompatibility during prenatal care. This led to limited knowledge about the pathology of the disease evidenced by the fact that most of the correct answers were between Questions 0-4, which were significantly associated with the women's education and income.

conclusionsAlthough hemolytic disease of the fetus and newborn is serious, the pregnant women in this study demonstrated little knowledge about the disease and had inadequate care by health professionals, reinforcing the importance of improving care for women's health and prenatal care.

Indexed as

Erythroblastosis fetalisHemolytic disease of the fetus and newbornIncompatibilityPregnant women

Identifiers

PMID38839547
PMCPMC11670607

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.